Table Of Contents

1. Introduction 50
1.1. Objectives Of The Study 50
1.2. Market Definition 50
1.3. Overview Of Europe Hemodialysis & Peritoneal Dialysis Market 50
1.4. Currency And Pricing 51
1.5. Limitation 52
1.6. Markets Covered 52
2. Market Segmentation 55
2.1. Markets Covered 55
2.2. Geographic Scope 56
2.3. Years Considered For The Study 57
2.4. Currency And Pricing 57
2.5. Research Methodology 58
2.6. Primary Interviews With Key Opinion Leaders 61
2.7. Secondary Sources 62
2.8. Assumptions 62
3. Market Overview 63
3.1. Drivers 65
3.1.1. Increased Number Of End Stage Renal Disease (Esrd) Patients 65
3.1.2. Increased Prevalance Of Diabetes And Hypertension 66
3.1.3. Preferance Of Patients For Dialysis Treatment Over Kidney Transplant 67
3.1.4. Rising Geriatric Population 68
3.1.5. R&D Investemnts In For Innovating Dialysis Products 68
3.1.6. Technological Advancements In The Products 70
3.1.7. Favorable Reimbursement Policy 71
3.2. Restraints 72
3.2.1. Risks Associated With The Treatment 72
3.2.2. Stringent Regulatory Framework 73
3.3. Opportunities 74
3.3.1. Increased Demand Of Homecare Settings For Dialysis Treatment 74
3.3.2. Low Cost And User Friendly Products Innovated 75
3.4. Challenges 76
3.4.1. Product Recalls 76
4. Executive Summary 77
5. Premium Insights 81
6. Europe Hemodialysis & Peritoneal Dialysis Market, By Type 88
6.1. Overview 89
6.2. Hemodialysis 91
6.3. Peritoneal Dialysis 92
7. Europe Hemodialysis Market, By Products And Services 93
7.1. Overview 94
7.2. Machines 96
7.2.1. Center-Use Hemodialysis Machines 98
7.2.2. Home-Use Hemodialysis Machines 98
7.3. Consumables 99
7.3.1. Dialyzers 101
7.3.1.1. Dialyzers Market, By Material Type 101
7.3.1.2. Dialyzers Market, By Flux Type 102
7.3.1.3. Hemodialysis Access Management Products Market, By Type 103
?
7.3.2. Bloodlines 104
7.3.3. Hemodialysis Concentrates 104
7.3.3.1. Alkaline 105
7.3.3.2. Acidic 105
7.3.4. Others 105
7.4. Services 106
7.4.1. In-Center Hemodialysis Services 107
7.4.2. Home Hemodialysis Services 107
8. Europe Hemodialysis Market, By Modality 108
8.1. Overview 109
8.2. Conventional Long-Term 111
8.3. Nocturnal 112
8.4. Short Daily 113
9. Europe Peritoneal Market, By Products And Services 114
9.1. Overview 115
9.2. Machines 117
9.3. Catheters 118
9.3.1. Short Term Catheters 119
9.3.2. Long Term Catheters 119
9.4. Transfer Sets 120
9.5. Concentrates 121
9.6. Services 122
9.7. Others 123
10. Europe Peritoneal Dialysis Market, By Modality 124
10.1. Overview 125
10.2. Continuous Ambulatory Peritoneal Dialysis 127
10.3. Automated Peritoneal Dialysis 128
11. Europe Hemodialysis Water Treatment Systems Market,
By Type 129
11.1. Overview 130
11.2. Portable Water Disinfection Systems 132
11.3. Central Water Disinfection Systems 133
11.3.1. Heat Disinfection Systems 134
11.3.2. Chemical Disinfection Systems 135
11.3.3. Accessories 135
12. Europe Hemodialysis And Peritoneal Dialysis Market,
By End User 136
12.1. Overview 137
12.2. Dialysis Centers 139
12.3. Hospitals 140
12.4. Home Care Settings 141
12.4.1. Peritoneal Dialysis 142
12.4.2. Home Hemodialysis 142
13. Europe Hemodialysis And Peritoneal Dialysis Market,
By Geography 143
13.1. Overview 144
13.3. Europe 193
13.3.1. Germany 209
13.3.2. France 218
13.3.3. U.K. 227
13.3.4. Italy 236
13.3.5. Spain 245
13.3.6. Switzerland 254
13.3.7. Netherlands 263
13.3.8. Turkey 272
13.3.9. Belgium 281
13.3.10. Russia 290
13.3.11. Rest Of Europe 299
14. Europe Hemodialysis And Peritoneal Dialysis Market, Company Landscape 457
14.3. Company Share Analysis; Europe 459
15. Company Profile 461
15.1. Davita Inc. 461
15.1.1. Company Overview 461
15.1.2. Davita, Inc.; Revenue Analysis 462
15.1.3. Product Portfolio 463
15.1.4. Recent Developments 464
15.2. Diaverum 465
15.2.1. Company Overview 465
15.2.2. Diaverum; Company Snapshot 465
15.2.3. Product Portfolio 466
15.2.4. Recent Developments 466
15.3. Nipro 467
15.3.1. Company Overview 467
15.3.2. Nipro Corporation; Revenue Analysis 468
15.3.3. Product Portfolio 469
15.3.4. Recent Developments 470
15.4. Nxstage Medical, Inc. 471
15.4.1. Company Overview 471
15.4.2. Nxstage Medical, Inc.; Company Snapshot 472
15.4.3. Product Portfolio 473
15.4.4. Recent Developments 474
15.5. Nikkiso Co., Ltd. 476
15.5.1. Company Overview 476
15.5.2. Nikkiso Co., Ltd.; Revenue Analysis 477
15.5.3. Product Portfolio 478
15.5.4. Recent Developments 478
15.6. Atlantic Biomedical Pvt. Ltd 479
15.6.1. Company Overview 479
15.6.2. Atlantic Biomedical Pvt. Ltd; Company Snapshot 479
15.6.3. Product Portfolio 480
15.6.4. Recent Developments 480
15.7. 3M 481
15.7.1. Company Overview 481
15.7.2. 3M; Company Snapshot 481
15.7.3. Product Portfolio 482
15.7.4. Recent Developments 482
15.8. C.R. Bard Inc. 483
15.8.1. Company Overview 483
15.8.2. C. R. Bard Inc.; Revenue Analyses 483
15.8.3. Product Portfolio 484
15.8.4. Recent Developments 484
15.9. Allmed Medical Co., Limited 485
15.9.1. Company Overview 485
15.9.2. Allmed Medical Co., Ltd; Company Snapshot 485
15.9.3. Product Portfolio 486
15.9.4. Recent Developments 486
15.10. Isopure Corp. 487
15.10.1. Company Overview 487
15.10.2. Isopure Corp ; Company Snapshot 487
15.10.3. Product Portfolio 488
15.10.4. Recent Developments 488
15.11. Cvp Medical Technology Co., Ltd 489
15.11.1. Company Overview 489
15.11.2. Cvp Medical Technology Co., Ltd.; Company Snapshot 489
15.11.3. Product Portfolio 490
15.11.4. Recent Developments 490
15.12. Mar Cor Purification Inc. 491
15.12.1. Company Overview 491
15.12.2. Mar Cor Purification; Company Snapshot 491
15.12.3. Product Portfolio 492
15.12.4. Recent Developments 494
15.13. Baxter 495
15.13.1. Company Overview 495
15.13.2. Baxter; Company Snapshot 495
15.13.3. Product Portfolio 496
15.13.4. Recent Developments 497
15.14. Medtronic 498
15.14.1. Company Overview 498
15.14.2. Medtronic; Rvenue Analysis 498
15.14.3. Product Portfolio 499
15.14.4. Recent Developments 499
15.15. Fresenius Group 500
15.15.1. Company Overview 500
15.15.2. Fresenius Group; Revenue Analysis 500
15.15.3. Product Portfolio 501
15.15.4. Recent Developments 502
15.16. B.Braun 503
15.16.1. Company Overview 503
15.16.2. B.Braun.; Company Snapshot 503
15.16.3. Product Portfolio 504
15.16.4. Recent Developments 504
?
15.17. Asahi Kasei Corporation 505
15.17.1. Company Overview 505
15.17.2. Asahi Kasei Corporation; Revenue Analysis 506
15.17.3. Product Portfolio 506
15.17.4. Recent Developments 507
15.18. Rockwell Medical, Inc. 508
15.18.1. Company Overview 508
15.18.2. Rockwell Medical, Inc.; Revenue Analysis 508
15.18.3. Product Portfolio 508
15.18.4. Recent Developments 509
15.19. Dialife Group 510
15.19.1. Company Overview 510
15.19.2. Dialife Group; Company Snapshot 510
15.19.3. Product Portfolio 511
15.19.4. Recent Developments 511
15.20. Jms Co., Ltd. 512
15.20.1. Company Overview 512
15.20.2. Jms Co., Ltd.; Company Snapshot 512
15.20.3. Product Portfolio 512
15.20.4. Recent Developments 513
16. Related Reports 515

?